1 Table of Contents_x000D_
1.1 List of Tables_x000D_
1.2 List of Figures_x000D_
2 Introduction_x000D_
2.1 What Is This Report About?_x000D_
2.2 Ophthalmic Devices Market Segmentation_x000D_
2.3 Definitions of Markets Covered in the Report_x000D_
3 Ophthalmic Devices Market, Japan_x000D_
3.1 Ophthalmic Devices Market, Japan, Revenue ($m), 2018-2033_x000D_
3.2 Ophthalmic Devices Market, Japan, Revenue Mix ($m), 2023_x000D_
3.3 Ophthalmic Devices Market, Japan, Category Contribution by Revenue ($m), 2023_x000D_
3.4 Ophthalmic Devices Market, Japan, Revenue ($m), 2018-2033_x000D_
3.5 Ophthalmic Devices Market, Japan, Volume (Units), 2018-2033_x000D_
3.6 Ophthalmic Devices Market, Japan, Volume (Units), 2018-2033_x000D_
3.7 Ophthalmic Devices Market, Japan, Company Share by Revenue ($m), 2023_x000D_
4 Corneal Implants Market, Japan_x000D_
4.1 Corneal Implants Market, Japan, Revenue Mix ($m), 2023_x000D_
4.2 Corneal Implants Market, Japan, Segment Contribution (%), 2023_x000D_
4.3 Corneal Implants Market, Japan, Revenue ($m), 2018-2033_x000D_
4.4 Corneal Implants Market, Japan, Volume (Units), 2018-2033_x000D_
4.5 Corneal Implants Market, Japan, Average Price ($), 2018-2033_x000D_
4.6 Corneal Implants Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
4.7 Corneal Implants Market, Japan, Company Share by Revenue ($m), 2023_x000D_
5 Glaucoma Surgery Devices Market, Japan_x000D_
5.1 Glaucoma Surgery Devices Market, Japan, Revenue Mix ($m), 2023_x000D_
5.2 Glaucoma Surgery Devices Market, Japan, Segment Contribution (%), 2023_x000D_
5.3 Glaucoma Surgery Devices Market, Japan, Revenue ($m), 2018-2033_x000D_
5.3.1 Glaucoma Drainage Devices Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_
5.4 Glaucoma Surgery Devices Market, Japan, Volume (Units), 2018-2033_x000D_
5.4.1 Glaucoma Drainage Devices Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_
5.5 Glaucoma Surgery Devices Market, Japan, Average Price ($) , 2018-2033_x000D_
5.6 Glaucoma Surgery Devices Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
5.7 Glaucoma Surgery Devices Market, Japan, Company Share by Revenue ($m), 2023_x000D_
6 Intraocular Lens (IOL) Market, Japan_x000D_
6.1 Intraocular Lens (IOL) Market, Japan, Revenue Mix ($m), 2023_x000D_
6.2 Intraocular Lens (IOL) Market, Japan, Segment Contribution (%), 2023_x000D_
6.3 Intraocular Lens (IOL) Market, Japan, Revenue ($m), 2018-2033_x000D_
6.3.1 Foldable IOL Market, Japan, Revenue ($m), by Segment, 2018-2033_x000D_
6.4 Intraocular Lens (IOL) Market, Japan, Volume (Units), 2018-2033_x000D_
6.4.1 Foldable IOL Market, Japan, Volume (Units), by Segment, 2018-2033_x000D_
6.5 Intraocular Lens (IOL) Market, Japan, Average Price ($) , 2018-2033_x000D_
6.6 Intraocular Lens (IOL) Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
6.7 Intraocular Lens (IOL) Market, Japan, Company Share by Revenue ($m), 2023_x000D_
7 Ophthalmic Lasers Market, Japan_x000D_
7.1 Ophthalmic Lasers Market, Japan, Revenue Mix ($m), 2023_x000D_
7.2 Ophthalmic Lasers Market, Japan, Segment Contribution (%), 2023_x000D_
7.3 Ophthalmic Lasers Market, Japan, Revenue ($m), 2018-2033_x000D_
7.4 Ophthalmic Lasers Market, Japan, Volume (Units), 2018-2033_x000D_
7.5 Ophthalmic Lasers Market, Japan, Average Price ($), 2018-2033_x000D_
7.6 Ophthalmic Lasers Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
7.7 Ophthalmic Lasers Market, Japan, Company Share by Revenue ($m), 2023_x000D_
8 Ophthalmic Viscoelastic Devices (OVD) Market, Japan_x000D_
8.1 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Revenue Mix ($m), 2023_x000D_
8.2 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Segment Contribution (%), 2023_x000D_
8.3 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Revenue ($m), 2018-2033_x000D_
8.4 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Volume (Units), 2018-2033_x000D_
8.5 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Average Price ($) , 2018-2033_x000D_
8.6 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Distribution Share by Revenue ($m), 2023_x000D_
8.7 Ophthalmic Viscoelastic Devices (OVD) Market, Japan, Company Share by Revenue ($m), 2023_x000D_
9 Overview of Key Companies in Japan, Ophthalmic Devices Market_x000D_
9.1 Carl Zeiss Meditec AG_x000D_
9.1.1 Company Overview_x000D_
9.2 Alcon Inc_x000D_
9.2.1 Company Overview_x000D_
9.3 Glaukos Corp_x000D_
9.3.1 Company Overview_x000D_
9.4 Johnson & Johnson Vision Care Inc_x000D_
9.4.1 Company Overview_x000D_
9.5 Allergan Aesthetics_x000D_
9.5.1 Company Overview_x000D_
9.6 Hoya Corp_x000D_
9.6.1 Company Overview_x000D_
9.7 SightLife_x000D_
9.7.1 Company Overview_x000D_
9.8 Bausch & Lomb Inc_x000D_
9.8.1 Company Overview_x000D_
9.9 STAAR Surgical Co_x000D_
9.9.1 Company Overview_x000D_
9.10 Santen Pharmaceutical Co Ltd_x000D_
9.10.1 Company Overview_x000D_
9.11 Aurolab_x000D_
9.11.1 Company Overview_x000D_
10 Ophthalmic Devices Market Pipeline Products_x000D_
11 Financial Deals Landscape_x000D_
11.1 Acquisition_x000D_
11.1.1 EssilorLuxottica Acquires
5.1% Stake in Nikon USD185.912 Million_x000D_
11.1.2 Furukawa Electric to Acquire Additional 40% Stake in MF Optex_x000D_
11.2 Debt Offerings_x000D_
11.2.1 Menicon to Raise USD67.20 Million in Public Offering of
0.964% Unsecured Straight Bonds Due 2029_x000D_
12 Recent Developments_x000D_
12.1 Corporate Communications_x000D_
12.1.1 May 30, 2024: Panasonic Holdings Announces Appointment and Assignment of Responsibilities of Executive Officers_x000D_
12.1.2 May 14, 2024: Menicon Notice of Agenda Items for the 67th Annual General Meeting of Shareholders (Election of Directors and Granting Stock Options)_x000D_
12.1.3 May 07, 2024: Panasonic Energy Announces Personnel Changes Relating to Executive Officers_x000D_
12.1.4 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5811VA)_x000D_
12.2 Financial Announcements_x000D_
12.2.1 Oct 31, 2024: Panasonic Holdings Reports Consolidated Financial Results for Six Months Ended September 30, 2024_x000D_
12.2.2 Aug 06, 2024: Santen Pharma Announces Consolidated Financial Results for the Three Months Ended June 30, 2024_x000D_
12.2.3 Aug 01, 2024: JVCKENWOOD Announces Financial Results for the Q1 of FYE March 31, 2025_x000D_
12.2.4 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-ST-C Dental Zirconia Block_x000D_
12.2.5 Jun 24, 2024: Zhejiang Zahndent Biotechnology Receives 510(K) Clearance For ZD-3D-Pro ML Dental Zirconia Block_x000D_
12.2.6 Jun 21, 2024: NX Development Enrolls First Patient in OVA-302 Study After FDA Orphan Designation for Gleolan_x000D_
12.2.7 Jun 17, 2024: OMNIVISION Announces Smallest Camera Module for 3D Intraoral Dental Scanners_x000D_
12.2.8 May 09, 2024: Panasonic Holdings Announces Results for Fiscal Year Ended March 31, 2024_x000D_
12.2.9 May 06, 2024: Microline Surgical Receives An Additional 510(k) Clearance For ReNew XR Handpiece_x000D_
12.2.10 May 06, 2024: Huizhou Foryou Medical Devices Receives An Additional 510(k) Clearance For LUOFUCON Collagen Wound Dressing_x000D_
12.2.11 May 06, 2024: UG GLOBAL RESOURCES SDN BHD Receives 510(K) Clearance For_x000D_
Black Pearl Nitrile Examination Glove_x000D_
12.2.12 May 06, 2024: Andon Health Receives 510(K) Clearance For Fully Automatic Electronic Blood Pressure Monitor (KD-5810VA)_x000D_
12.2.13 May 02, 2024: Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy_x000D_
12.2.14 Apr 22, 2024: Biovis Vascular Biological Mesh Was Approved for Registration_x000D_
12.3 Legal And Regulatory_x000D_
12.3.1 Sep 06, 2024: Fujifilm Healthcare Europe Announces ARIETTA 750 FF ENDO Compatibility with Fujifilm Ultrasound Endoscopes and Endobronchial Ultrasound Scope_x000D_
12.3.2 Feb 01, 2024: Carl Zeiss Meditec Reaches Favorable Legal Settlement with Topcon_x000D_
13 Appendix_x000D_
13.1 Research Methodology_x000D_
13.1.1 Coverage_x000D_
13.1.2 Secondary Research_x000D_
13.1.3 Primary Research_x000D_
13.1.4 Market Modeling and Forecasting_x000D_
13.1.5 Company Share Analysis_x000D_
13.1.6 Distribution Share Analysis_x000D_
13.1.7 Benchmarking_x000D_
13.2 GlobalData Consulting_x000D_
13.3 Contact Us_x000D_
13.4 Disclaimer